Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury
Status:
Terminated
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to compare the clinical outcomes of cure and recurrence
of Clostridium difficile infection in spinal cord injured patients who are treated with oral
Fidaxomicin vs. oral Vancomycin. The secondary aim of this study is to compare the overall
costs of treatment of Clostridium difficile infection in the two study groups.